- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Medical Bulletin 18/November/2022 - Video
Overview
A study of close to 12000 people in six European countries has shown that people with type 2 diabetes who develop cancer are more likely to be diagnosed with advanced disease if the condition is one that is not screened for routinely. Study was presented in the 13th European Breast Cancer Conference.
Reference:
More cancers are diagnosed at an advanced stage if patients already have type 2 diabetes; EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER; MEETING- 13th European Breast Cancer Conference (EBCC13).
Cannabis not made safer by increasing its CBD content
Cannabis nowadays is widely used for recreational and medicinal drugs. New research from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King's College London has found no evidence that cannabidiol (CBD) reduces the negative effects of cannabis.
The research, published in Neuropsychopharmacology, challenges the commonly held belief that using cannabis that contains higher levels of cannabidiol protects the user from psychotic experiences and memory problems, and suggests that this should be considered by policy makers currently exploring the topic of medicinal and recreational use.
Reference:
Cannabis not made safer by increasing its CBD content; KING'S COLLEGE LONDON; JOURNAL: Neuropsychopharmacology, DOI: 10.1038/s41386-022-01478-z.
Persistent hematuria associated with strong risks of chronic kidney disease
Hematuria, as we all know is characterized by the presence of blood in the urine, has been reported to be associated with increased risk of chronic kidney disease (CKD). However, the relationship between hematuria that persists over time and kidney function is not clear. This present study, recently published in the American Journal of Kidney Disease (AJKD) reveals the importance of monitoring hematuria.
Reference:
Persistent hematuria associated with strong risks of chronic kidney disease; NATIONAL KIDNEY FOUNDATION, JOURNAL- American Journal of Kidney Diseases; DOI-10.1053/j.ajkd.2022.09.012
Speakers
Dr. Nandita Mohan
BDS, MDS( Pedodontics and Preventive Dentistry)